Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003763 · ClinicalTrials.gov registry record · NA
Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer
A NA study, sponsored by Endocyte.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT00003763: Completed NA study, sponsored by Endocyte.
NCT00003763 is a NA study that has completed, run by Endocyte. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003763, a NA study, has completed, sponsored by Endocyte.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures using the drug radiolabeled folic acid and imaging may be effective in detecting ovarian cancer. PURPOSE: Diagnostic trial to study the effectiveness of radiolabeled folic acid plus imaging in detecting ovarian cancer.
Interventions
- PROCEDURE radionuclide imaging
- RADIATION indium In 111 folic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 1997-12-08 |
| Est. Completion | 2000-05-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003763
The ClinicalTrials.gov registry entry for NCT00003763 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endocyte, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which radionuclide imaging is the first listed.
NCT00003763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003763 about?
NCT00003763 is a clinical study titled "Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer". RATIONALE: Diagnostic procedures using the drug radiolabeled folic acid and imaging may be effective in detecting ovarian cancer. PURPOSE: Diagnostic trial to study the effectiveness of radiolabeled folic acid plus imaging in detecting ovarian cancer.
What is the current status of trial NCT00003763?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 1997-12-08. Estimated completion is 2000-05-03.
What interventions are being tested in trial NCT00003763?
The interventions under investigation include: radionuclide imaging (PROCEDURE), indium In 111 folic acid (RADIATION).
Who is sponsoring clinical trial NCT00003763?
This trial is sponsored by Endocyte, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.